Latest Strategic Partnerships News

Page 1 of 311
Sparc Technologies has appointed former Micro-X chief executive Kingsley Hall to lead its graphene additives and green hydrogen businesses into their next commercial phase. The transition gives Hall an immediate mandate to grow ecosparc sales and advance Sparc Hydrogen beyond pilot operations, while his incentive package ties part of his reward to shareholder returns and revenue milestones.
Sophie Babbage
Sophie Babbage
19 Nov 2026
Lake Resources says its Kachi lithium project in Argentina is now shovel-ready, with environmental approval secured, FEED underway and a revised Phase One plan showing lower capital costs. The harder test now is turning that progress into RIGI approval, financing, offtake agreements and a final investment decision.
Maxwell Dee
Maxwell Dee
19 Nov 2026
Xenitra has secured a three-year strategic cooperation agreement with JD Health carrying a non-binding A$100 million sales target across prescription medicines, OTC products, FSMP products and health products. The first order is expected in December, with sales targeted to begin in January 2027, but the agreement does not guarantee revenue or impose a penalty if the target is missed.
Victor Sage
Victor Sage
18 Nov 2026
Epiminder has signed a five-year rolling partnership with Stratus Neuro to integrate its long-term Minder EEG data into StratusEEG, a cloud platform used by more than 7,000 US clinicians and administrators. The agreement gives Epiminder an established clinical workflow for its DETECT study and planned US commercialisation, although no financial terms or launch date were disclosed.
Victor Sage
Victor Sage
17 Nov 2026
Aldoro Resources says Wood Mackenzie has set a long-term forecast price of about US$6,900 per tonne for Kameelburg’s mixed rare earth carbonate, while a separate strontium carbonate stream could add another chemical product. The figures will feed into a Scoping Study that is nearing completion, but depend partly on purity targets not yet achieved.
Maxwell Dee
Maxwell Dee
17 Nov 2026
Australian Mines has appointed Tribeca Capital Advisory as corporate adviser as it seeks funding, offtake and strategic partners for its 100%-owned Flemington Scandium Project. The appointment comes with A$4.6 million in cash and a pre-feasibility study targeted for mid-Q1 2027, but no financing or commercial deal has yet been secured.
Maxwell Dee
Maxwell Dee
12 Nov 2026
Litchfield Minerals has made a potential Harts Range partnership the centrepiece of its 2027 strategy, with BHP expected to take the project to its investment committee later this month. The explorer is also trimming holding costs, separating non-core assets and seeking a second drill-ready copper or gold project.
Maxwell Dee
Maxwell Dee
9 Nov 2026
Aldoro has signed an MOU that would give WILLETECH a 51% stake in the Kameelburg project company and put the Namibian rare earths project on a proposed path to commercial production. The headline RMB2 billion funding commitment remains non-binding, however, with definitive agreements, approvals and proof of financing still outstanding.
Maxwell Dee
Maxwell Dee
5 Nov 2026
Strategic Elements has secured its first commercial mining contract for Stealth Technologies’ EdgeiQ OnSite platform, worth approximately A$225,000 initially. A separate EdgeiQ Portable pilot has also launched after five underground trials with a Tier 1 mining company, giving the venture two potential routes into mining operations.
Victor Sage
Victor Sage
5 Nov 2026
Aldoro Resources has entered voluntary suspension on the ASX while it prepares to announce a significant strategic partnership agreement. The market has been given no details on the proposed partner, terms or financial impact.
Maxwell Dee
Maxwell Dee
4 Nov 2026
Terrain Minerals has completed a $1.65 million placement and entitlement offer, but still has $856,872 of shortfall securities available to place. The funds are supporting an 86-hole Lightning drilling campaign aimed at upgrading the project’s mineral resource in Q2 2027.
Maxwell Dee
Maxwell Dee
4 Nov 2026
Neurizon Therapeutics has secured A$4.3 million through a discounted placement and is seeking another A$2.0 million from eligible shareholders, while redeeming its remaining Obsidian convertible notes. The move removes current note-conversion dilution, but shifts funding risk towards equity holders ahead of a pivotal NUZ-001 trial readout.
Ada Torres
Ada Torres
2 Nov 2026

Browse the archive

Full archive